Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
The mTOR signalling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC).